logo


Life Science Leaders to Discuss Finding Investors in a Tough Economy
Thursday, May 07, 2009 11:02 AM


(Source: Business Wire)tracking
  WHAT:    Join regional life science and investment executives for an analysis of the challenges facing the biotechnology sector in the wake of the lingering financial crisis. Ernst & Young, in its annual report on the biotechnology sector, just Tuesday declared the present biotechnology business model "unsustainable." The Wall Street Journal has reported that one-third of publicly-traded biotechs have less than six-months cash on hand -- a 1,000 percent increase from 2008.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Biopharmaceutical companies around the country have been crushed by the meltdown of the financial markets, jeopardizing research and technology that could impact thousands of lives. A life science symposium hosted by Yankee Public Relations will focus on this important issue. NJBIZ, New Jersey's statewide business journal, is the exclusive media sponsor for the event.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     WHO:     Yankee PR President Fred Feiner will moderate three panels focused on successful finance strategies, the current investment market and regulatory tactics to maximize profitability. Confirmed panelists include:                                                                                                                                                                                                                                                                               -- Annarie Lyles, Ph.D., Genmab (OMX: GEN), SVP/Head of Business Development                                                                                                                                                                                                                                                                                                                                                                                                                    -- Evan Myrianthopoulos, DOR Biopharma (OTCBB: DORB), CFO and SVP                                                                                                                                                                                                                                                                                                                                                                                                                               -- Ellen McDonald, M.B.A., Regado Biosciences, SVP, Business Operations and Chief Business Officer                                                                                                                                                                                                                                                                                                                                                                                              -- Andrew Reaume, Ph.D., M.B.A., Melior Discovery, President/CEO                                                                                                                                                                                                                                                                                                                                                                                                                                -- Jeffrey H. Nicholas, J.D., Fox Rothschild, Partner/Chair, Technology, Venture Finance and Securities Practices                                                                                                                                                                                                                                                                                                                                                                               -- John Pennett, C.P.A, Amper, Politziner & Mattia, Partner/Director of Life Sciences Practice                                                                                                                                                                                                                                                                                                                                                                                                  -- Emilio Ragosa, J.D., Morgan Lewis, Partner in Business Finance                                                                                                                                                                                                                                                                                                                                                                                                                               -- Gene Detroyer, Five Prime Advisors, Director                                                                                                                                                                                                                                                                                                                                                                                                                                                 -- Avjit Roy, Ph.D., Five Prime Advisors, Director                                                                                                                                                                                                                                                                                                                                                                                                                                              -- Mike Page, United Biosource Corporation, Senior Director of Regulatory Affairs                                                                                                                                                                                                                                                                                                                                                                                                               -- Nigel Smart, Ph.D., Smart Consulting Group, Managing Partner                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        WHEN:    Tuesday, June 9, 2009, 8 a.m.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          WHERE:   Basking Ridge Country Club, 185 Madisonville Rd., Basking Ridge, NJ                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    COST:    Registration fee for the symposium: $30. Note: Register by Friday, June 5 as on-site registration will not be available. Qualified media can attend for free. Please visit www.yankeepr.com for information or contact Feiner at 908-894-3930 or fred@yankeepr.com.                                                                                                                                                                                                                     -------------------------------------------------------------------------------  

Yankee Public Relations

Yankee Public Relations LLC is a full-service, boutique marketing communications firm with more than 45 years of combined experience leading proactive media relations and marketing communications initiatives in the life sciences and finance industries.

A service of YellowBrix, Inc.



(0)
No Comments
Post Comment
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
   
 
 
 
 
   
 

  
Related Press Releases
Advertisement
Popular Articles
Special Offers
Partner Center
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia